Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03600909
What this trial is testing

The Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia

Who this might be right for
Fanconi AnemiaMyelodysplastic Syndrome (MDS)Acute Myelogenous Leukemia (AML)
Memorial Sloan Kettering Cancer Center 3
Testing effectiveness (Phase 2)UnknownNCT01513109
What this trial is testing

Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia

Who this might be right for
Acute Myelogenous LeukemiaMyeloid Leukemia in RemissionEffects of Immunotherapy
Jules Bordet Institute 20
Early research (Phase 1)Looking for participantsNCT06543381
What this trial is testing

Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center 15
Testing effectiveness (Phase 2)Looking for participantsNCT04888741
What this trial is testing

Methods of T Cell Depletion Trial (MoTD)

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelomonocytic Leukemia+6 more
University of Birmingham 400
Testing effectiveness (Phase 2)Ended earlyNCT01530256
What this trial is testing

Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD)

Who this might be right for
Acute GvHD
CSL Behring 3
Early research (Phase 1)Ended earlyNCT01745354
What this trial is testing

Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT)

Who this might be right for
Lymphoma, Non-HodgkinHodgkin Disease
Robert Lowsky 6
Testing effectiveness (Phase 2)Ended earlyNCT01488253
What this trial is testing

Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants

Who this might be right for
Acute Leukemia in RemissionMyelodysplastic SyndromesLeukemia, Myeloid, Chronic-Phase+1 more
The Korean Society of Blood and Marrow Transplantation 3
Testing effectiveness (Phase 2)Study completedNCT02472691
What this trial is testing

Azacitidine, Lenalidomide and DLI as Salvage Therapy for MDS, CMML and sAML Relapsing After Allo-HSCT

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Heinrich-Heine University, Duesseldorf 50
Testing effectiveness (Phase 2)UnknownNCT05841771
What this trial is testing

Hypomethylating Agent and Venetoclax After Allo-HSCT in Patients With High-risk Myeloid Malignancies.

Who this might be right for
Hypomethylating AgentVenetoclaxMyeloid Malignancy
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 78
Early research (Phase 1)Study completedNCT04555811
What this trial is testing

FT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHL

Who this might be right for
NHLNon Hodgkin LymphomaDiffuse Large B Cell Lymphoma+1 more
Masonic Cancer Center, University of Minnesota 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06986382
What this trial is testing

Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refractory Crohn Disease

Who this might be right for
Crohn Disease
Stanford University 14
Early research (Phase 1)WithdrawnNCT02276820
What this trial is testing

Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)

Who this might be right for
Adenovirus Infection
AlloVir
Large-scale testing (Phase 3)Ended earlyNCT03870750
What this trial is testing

Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmNon-Neoplastic Hematologic and Lymphocytic Disorder
Fred Hutchinson Cancer Center 458
Testing effectiveness (Phase 2)Looking for participantsNCT06783790
What this trial is testing

Avapritinib Combined With Azacitidine and Venetoclax in the Treatment of Relapsed AML After Allo-HSCT

Who this might be right for
AML (Acute Myelogenous Leukemia)
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableUnknownNCT06241274
What this trial is testing

Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT

Who this might be right for
MoxibustionHematopoietic Stem Cell TransplantationHemorrhagic Cystitis+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Not applicableNot Yet RecruitingNCT06582797
What this trial is testing

Analytical Treatment Interruption in a Patient With HIV Post Allogeneic Stem Cell Transplantation From a CCR5 delta32 Homozygous Donor

Who this might be right for
HIV-1-infection
University of Kansas Medical Center 10
Not applicableStudy completedNCT04506320
What this trial is testing

Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaStem Cell Transplant
Gruppo Italiano Trapianto di Midollo Osseo 202
Large-scale testing (Phase 3)Study completedNCT00557817
What this trial is testing

Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Hematological Malignancies
University of Liege 125
Early research (Phase 1)Looking for participantsNCT04593589
What this trial is testing

Submandibular Gland Stem Cell Transplantation

Who this might be right for
Head and Neck Cancer
University Medical Center Groningen 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06075238
What this trial is testing

Blinatumomab Prevents Recurrence of R/R ALL After Allo-HSCT

Who this might be right for
Leukemia, Lymphoid
Sichuan University 68
Next Page